The Department of Health’s request for P1 billion to procure remdesivir, an anti-viral drug used for treating COVID-19 patients, faced criticism from lawmakers on Monday. Buhay Partylist Rep. Lito Atienza questioned the efficacy of the cocktail drug and DOH’s double standard despite World Health Organization discouraging its use. “It doesn’t shorten the clinical treatment, it …

The post Lawmakers question DOH‘s request for Php1 billion fund to buy remdesivir appeared first on The Filipino Times.